Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/HSA/ENAPRIL- 5 TABLET 5 mg

Approved

THERAPEUTIC

ENAPRIL- 5 TABLET 5 mg

INTAS PHARMACEUTICALS LTDIntas Pharmaceuticals Ltd.🇸🇬 Health Sciences Authority

Approval Date: Jun 21, 2001
Approval ID: 376d819313ca0a0c
Company: INTAS PHARMACEUTICALS LTDIntas Pharmaceuticals Ltd.
Type: Therapeutic

Approval Details

Approval Id: 376d819313ca0a0c
Drug Name: ENAPRIL- 5 TABLET 5 mg
Product Name: ENAPRIL- 5 TABLET 5 mg
Approval Number: SIN11572P
Approval Date: 2001-06-21
Registrant: APOTHECA MARKETING PTE LTD
Licence Holder: APOTHECA MARKETING PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: C09AA02
Atc Item Name: enalapril
Pharma Manufacturer Name: APOTHECA MARKETING PTE LTD
Company Detail Path: /organization/apotheca-marketing-pte-ltd

Active Ingredients

ENALAPRIL MALEATE

5.000 mg

ENALAPRIL MALEATE

5.000 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 21, 2001

Approval ID

376d819313ca0a0c

Type

Therapeutic

Back to HSA Approvals

ENAPRIL- 5 TABLET 5 mg - HSA Drug Approval Details